South Korean pharmaceutical firms lose appeal against vaccine bid-rigging fine
Several South Korean pharmaceutical companies and drug distributors have failed in their attempt to overturn a 2023 antitrust fine imposed by the South Korean competition regulator for bid-rigging in the government’s...To view the full article, register now.
Already a subscriber? Click here to view full article